Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @SCIDirector
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @SCIDirector
-
Bass Center recently opened a new inpatient unit
@StanfordChild featuring hematology, oncology, and stem cell transplant services, with expanded surgery, imaging, and diagnostic capacities. https://prn.to/2EgGtGl#childhoodcancerpic.twitter.com/029v7gGVw6Thanks. Twitter will use this to make your timeline better. UndoUndo -
SCI member Crystal Mackall and colleagues modified
#CARTcells to remain active in mice even under conditions that would normally result in their exhaustion - important implications for developing the next generation of#cancer#immunotherapy treatments. https://stan.md/2PjONKy pic.twitter.com/hAwV3y0cInThanks. Twitter will use this to make your timeline better. UndoUndo -
Don't forget to check out SCI member Russ Altman at the
#ASH19 Presidential Symposium on Tuesday 12/10: Role of Pharmacogenomics, Computational Biology, and Other "Omics" Approaches in Precision Medicine and Regulatory Science http://bit.ly/2OJ7c40@Rbaltmanpic.twitter.com/lDq0EbxuS7Thanks. Twitter will use this to make your timeline better. UndoUndo -
SCI member Lori Muffly will speak at
#ASH19 on Monday 12/9 morning and afternoon: Acute Lymphoblastic Leukemia: Pediatric-inspired Protocols in Adult ALL: Are the Results Bearing Fruit? http://bit.ly/34HxucP pic.twitter.com/v1EnrLAGiWThanks. Twitter will use this to make your timeline better. UndoUndo -
Steven Artandi, MD, PhD Retweeted
In a recent episode of "The Future of Everything," host Russ Altman and guest Ross Shachter discussed the role of
#AI in improving malignant tumor detection accuracy.https://stan.md/389tgg0Thanks. Twitter will use this to make your timeline better. UndoUndo -
Highly recommended
#ASH19 session for trainees! SCI member Ami Bhatt will present at Sunday's Special Interest Session: TRTH Symposium: A Decade of Training the Future Leaders in Translational Research, 4:30-6:30 PM in W314. http://bit.ly/35ZvFIp#ASHTraineepic.twitter.com/FnIUmNsl5JThanks. Twitter will use this to make your timeline better. UndoUndo -
Don't miss SCI leader
@AshAlizadeh on Friday 12/6 at#ASH19: Liquid Biopsies As Integrated Biomarkers in Pediatric and Adult Hematologic Malignancies, 3:55-4:45 PM in W222. http://bit.ly/2P9yNKM pic.twitter.com/t0nijID5UpThanks. Twitter will use this to make your timeline better. UndoUndo -
#ASH19 is almost here! I'll be sharing recommendations for exciting talks by SCI members. First up, Ravi Majeti's talk at Friday's Scientific Workshops: Modeling RUNX1-FPD/Acute Myeloid Leukemia Mutations in Primary Human Hematopoietic Stem Cells. http://bit.ly/2qUQPbP pic.twitter.com/vOjnv1G061Thanks. Twitter will use this to make your timeline better. UndoUndo -
SCI member James Brooks discusses the risks and benefits of PSA testing, and clarifies some misconceptions about
#prostatecancer screening. https://stan.md/2r6IIJa#pcsmThanks. Twitter will use this to make your timeline better. UndoUndo -
SCI leader Sam Gambhir is leading the way in finding innovative ways to detect cancer early. Join us in raising awareness for the potentially lifesaving benefits of cancer screening. Learn more at http://CancerScreenWeek.org
@CanaryCenter#CancerScreenWeekpic.twitter.com/qFCLNDP7quThanks. Twitter will use this to make your timeline better. UndoUndo -
This
#Thanksgiving, I am thankful for our amazing clinicians, researchers, staff, students, and patients who inspire me each and every day. It is an honor to be part of our SCI community!pic.twitter.com/riH2fjE4B0Thanks. Twitter will use this to make your timeline better. UndoUndo -
SCI member Ranjana Advani and colleagues explore the prognostic significance of MYC rearrangement and translocation partner in diffuse large b-cell
#lymphoma, and discuss diagnostic and therapeutic implications for certain patients. http://bit.ly/2KUwSsh@JCO_ASCO#dlbc#lymcsmpic.twitter.com/xaBnQNwkGyThanks. Twitter will use this to make your timeline better. UndoUndo -
SCI member Youn Kim and colleagues found in a phase II trial that pembrolizumab demonstrated significant antitumor activity, with durable responses and a favorable safety profile, in patients with advanced
#mycosisfungoides and#sezarysyndrome. http://bit.ly/347LHiC@JCO_ASCOpic.twitter.com/ebKipi2M22Thanks. Twitter will use this to make your timeline better. UndoUndo -
SCI members Jim Ford and Michael Snyder used deep bisulfite sequencing to find that DNA methylation may play a broader role in early-onset familial
#breastcancer. http://bit.ly/2pD3Yph#bcsm#personalgenomics@SnyderShot@CCR_AACRThanks. Twitter will use this to make your timeline better. UndoUndo -
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Tied at 10 in the Big Game midway through second quarter go
@StanfordFball!#biggamepic.twitter.com/DGI7UUMG7XThanks. Twitter will use this to make your timeline better. UndoUndo -
.
@CochranLab and@SLAClab researchers identified unique characteristics of VISTA, an immune checkpoint protein that inhibits T cell response against#cancer. Their insights could guide future development of drugs that target these proteins.http://bit.ly/331th1JThanks. Twitter will use this to make your timeline better. UndoUndo -
Congratulations to Hongjie Dai, Julie Parsonnet and Joseph Wu on being elected to the National Academy of Medicine! Proud to have you as members of the Cancer Institute. https://stan.md/330t7HW
@theNAMedicine@StanfordCVIpic.twitter.com/ECXQo5LDuCThanks. Twitter will use this to make your timeline better. UndoUndo -
Steven Artandi, MD, PhD Retweeted
Excited to share our work on searching for therapeutic strategies for diffuse midline gliomas, that also uncovered metabolic vulnerabilities in this fatal childhood brain tumor. https://stm.sciencemag.org/content/11/519/eaaw0064.full …
@michelle_monjehttps://www.nih.gov/news-events/news-releases/scientists-find-promising-drug-combination-against-lethal-childhood-brain-cancers …Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo -
SCI members Crystal Mackall and Robbie Majzner discuss major factors affecting the efficacy of
#CARTcell therapy, lessons learned from clinical trials, and future directions for#immunotherapy research. https://go.nature.com/33NyTOm@NatureMedicinepic.twitter.com/KtFXyf5Q6BThanks. Twitter will use this to make your timeline better. UndoUndo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.